Cargando…
Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027819/ https://www.ncbi.nlm.nih.gov/pubmed/35459155 http://dx.doi.org/10.1186/s12885-022-09568-3 |
| _version_ | 1784691462071386112 |
|---|---|
| author | Guru, Sameer Ahmad Sumi, Mamta Pervin Mir, Rashid Beg, Mirza Masroor Ali koner, Bidhan Chandra Saxena, Alpana |
| author_facet | Guru, Sameer Ahmad Sumi, Mamta Pervin Mir, Rashid Beg, Mirza Masroor Ali koner, Bidhan Chandra Saxena, Alpana |
| author_sort | Guru, Sameer Ahmad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9027819 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90278192022-04-23 Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival Guru, Sameer Ahmad Sumi, Mamta Pervin Mir, Rashid Beg, Mirza Masroor Ali koner, Bidhan Chandra Saxena, Alpana BMC Cancer Correction BioMed Central 2022-04-22 /pmc/articles/PMC9027819/ /pubmed/35459155 http://dx.doi.org/10.1186/s12885-022-09568-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Guru, Sameer Ahmad Sumi, Mamta Pervin Mir, Rashid Beg, Mirza Masroor Ali koner, Bidhan Chandra Saxena, Alpana Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival |
| title | Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival |
| title_full | Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival |
| title_fullStr | Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival |
| title_full_unstemmed | Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival |
| title_short | Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival |
| title_sort | correction: aberrant hydroxymethylation in promoter cpg regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027819/ https://www.ncbi.nlm.nih.gov/pubmed/35459155 http://dx.doi.org/10.1186/s12885-022-09568-3 |
| work_keys_str_mv | AT gurusameerahmad correctionaberranthydroxymethylationinpromotercpgregionsofgenesrelatedtothecellcycleandapoptosischaracterizesadvancedchronicmyeloidleukemiadiseasepoorimatinibrespondentsandpoorsurvival AT sumimamtapervin correctionaberranthydroxymethylationinpromotercpgregionsofgenesrelatedtothecellcycleandapoptosischaracterizesadvancedchronicmyeloidleukemiadiseasepoorimatinibrespondentsandpoorsurvival AT mirrashid correctionaberranthydroxymethylationinpromotercpgregionsofgenesrelatedtothecellcycleandapoptosischaracterizesadvancedchronicmyeloidleukemiadiseasepoorimatinibrespondentsandpoorsurvival AT begmirzamasroorali correctionaberranthydroxymethylationinpromotercpgregionsofgenesrelatedtothecellcycleandapoptosischaracterizesadvancedchronicmyeloidleukemiadiseasepoorimatinibrespondentsandpoorsurvival AT konerbidhanchandra correctionaberranthydroxymethylationinpromotercpgregionsofgenesrelatedtothecellcycleandapoptosischaracterizesadvancedchronicmyeloidleukemiadiseasepoorimatinibrespondentsandpoorsurvival AT saxenaalpana correctionaberranthydroxymethylationinpromotercpgregionsofgenesrelatedtothecellcycleandapoptosischaracterizesadvancedchronicmyeloidleukemiadiseasepoorimatinibrespondentsandpoorsurvival |